Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ACTRN12625000479404) titled 'A Phase 2 Study of BRP-180 in Patients with Narcolepsy' on May 19.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Primary Sponsor: Bioron Pharma
Condition:
Narcolepsy
Narcolepsy
Neurological - Other neurological disorders
Intervention:
The trial will consist of a screening, observation period, treatment period, and a follow-up (FU) period.
During the screening and observational period (up to 42 days before begining treatment), participants are expected to complete daily sleep and cataplexy diaries, Daily questionnaires ...